Fesoterodine
Toviaz
NADAC/unit
$0.8239
No Shortage
Tier 1: 29.2%
PA Req: 0.6%
7 Manufacturers
14 ANDAs
Fesoterodine fumarate extended-release tablets are indicated for the treatment of: Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. ( 1.1 ) 1.1....
vs. brand Toviaz: Generic saves up to 92% per unit
Market Intelligence
2026-01-14 Class III Recall: Alembic Pharmaceuticals Limited
2025-11-26 Class III Recall: Alembic Pharmaceuticals Limited
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDAMNEAL PHARMACEUTICALS OF NY LLCAUROBINDO PHARMA LTDDR REDDYS LABORATORIES LTDHETERO LABS LTD UNIT VPFIZER INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.